WASHINGTON, D.C. (LifeSiteNews) — The U.S. Food and Drug Administration (FDA) under President Joe Biden is further relaxing the rules for homosexuals to donate blood and recommending a new set of questions and conditions that would apply to all prospective donors regardless of sexual preference.
The FDA recommends that the current guidelines, under which men who have sexual relations with other men are to abstain for three months before giving blood, be replaced with a set of “individual risk-based questions” that would be asked of everyone, regardless of biological sex or sexual attraction.
Specifically, anyone who reports engaging in sodomy with a new partner or multiple partners within three months of applying would be deferred for three months, but those practicing sodomy within a three-month window with an established partner would not be disqualified. Those currently taking HIV medication would remain ineligible to donate.
“The implementation of these recommendations will represent a significant milestone for the agency and the LGBTQI+ community,” said FDA Center for Biologics Evaluation & Research director Peter Marks. “The FDA has worked diligently to evaluate our policies and ensure we had the scientific evidence to support individual risk assessment for donor eligibility while maintaining appropriate safeguards to protect recipients of blood products.”
An unfettered right to donate blood has long been one of LGBT activists’ more commonly overlooked goals, despite the risks of relaxing donation standards in the name of “equality.”
In 2015, the Associated Press acknowledged that “men who have had sex with other men represent about 2 percent of the U.S. population, yet account for at least 62 percent of all new HIV infections in the U.S.” A 2013 report from the U.S. Centers for Disease Control and Prevention found that approximately 62 percent of homosexual men who knew they were infected with HIV/AIDS continued engaging in unprotected sex anyway.
Also in 2015, the FDA under former President Barack Obama lifted its longstanding ban on accepting blood from homosexuals, replacing it with a one-year waiting period. In 2020, the FDA under former President Donald Trump shortened the period from one year to three months, citing the need for blood during the COVID-19 pandemic.
Promotion of homosexuality and transgenderism through all facets of government has been among the top priorities of the Biden administration.
RELATED
Illinois gov. legalizes spreading HIV, mandates that insurance companies cover IVF for homosexuals